Biotest GmbH & Co. KGaA (HAM:BIO0)
Germany · Delayed Price · Currency is EUR 33.20
0.00 (0.00%)
At close: Aug 14, 2026
Biotest GmbH & Co. KGaA Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -70.7 | 26.4 | 127 | -31.7 | -63.4 |
Depreciation & Amortization | 38.8 | 40.5 | 35.8 | 35.8 | 31.1 |
Other Amortization | 0.2 | 0.1 | 0.1 | - | - |
Loss (Gain) From Sale of Assets | - | -0.1 | -23.1 | - | - |
Loss (Gain) on Equity Investments | - | 14 | -2.4 | 0.7 | -1.3 |
Provision & Write-off of Bad Debts | 4 | -7.9 | - | - | - |
Other Operating Activities | 11.3 | -11.9 | 28.4 | -0.1 | 45.9 |
Change in Inventory | -118.9 | -11.4 | -213.4 | -76.1 | 23.8 |
Change in Accounts Payable | -9.5 | 7 | 45.3 | 24.8 | - |
Change in Other Net Operating Assets | -0.1 | 4.2 | -0.4 | 6.1 | -2.3 |
Operating Cash Flow | -144.9 | 60.9 | -2.7 | -40.5 | 33.8 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -11.6 | -28.7 | -33.4 | -29.3 | -18.2 |
Sale of Property, Plant & Equipment | 0.5 | 0.2 | 1 | - | 0.3 |
Divestitures | - | - | 35 | - | - |
Investment in Securities | 1.3 | 1.7 | -2.4 | -7.8 | -5.5 |
Other Investing Activities | 1.2 | 1.1 | 1.1 | 0.1 | - |
Investing Cash Flow | -8.6 | -25.7 | 1.3 | -37 | -23.4 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 149.7 | 197.4 | 10.1 | 100 | 25.1 |
Long-Term Debt Repaid | -6.3 | -230.2 | -19 | -5.8 | -5.3 |
Net Debt Issued (Repaid) | 143.4 | -32.8 | -8.9 | 94.2 | 19.8 |
Common Dividends Paid | -0.8 | -1.6 | - | -0.8 | -0.8 |
Other Financing Activities | -7.2 | -1 | 2.1 | -3.8 | 3.6 |
Financing Cash Flow | 135.4 | -35.4 | -6.8 | 89.6 | 22.6 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.1 | -0.1 | 0.1 | - | - |
Miscellaneous Cash Flow Adjustments | - | - | -0.4 | 0.1 | 0.1 |
Net Cash Flow | -18 | -0.3 | -8.5 | 12.2 | 33.1 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -156.5 | 32.2 | -36.1 | -69.8 | 15.6 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -24.12% | 4.43% | -5.27% | -13.53% | 3.03% |
Free Cash Flow Per Share | -3.96 | 0.81 | -0.91 | -1.76 | 0.39 |
Levered Free Cash Flow | -106.11 | -17.49 | -68.74 | -71.69 | 28.64 |
Unlevered Free Cash Flow | -84.61 | 1.45 | -45.86 | -60.13 | 36.39 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 18.1 | 20.3 | 24.2 | 13.1 | 12.8 |
Cash Income Tax Paid | 1.5 | 8.7 | 11.7 | 2 | 0.9 |
Change in Working Capital | -128.5 | -0.2 | -168.5 | -45.2 | 21.5 |